Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
Completed · Phase 2 · Has a placebo group
Conditions studied: Hypertension
In brief
The study examined the efficacy of LCZ696 in comparison to the ARB olmesartan on Central Aortic Systolic Blood Pressure (CASP) and other measures of central hemodynamics and arterial stiffness in elderly patients with an elevated systolic blood pressure (SBP) and widened pulse pressure (PP).
Key facts
- Study ID
- NCT01692301
- Run by
- Novartis Pharmaceuticals
- People needed
- 454
- Starts
- 2012-12-01
- Expected to finish
- 2015-04-01
- Last updated by the study team
- 2016-05-04
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Clearwater, Florida, United States
- Novartis Investigative Site — Chicago, Illinois, United States
- Novartis Investigative Site — Baltimore, Maryland, United States
- Novartis Investigative Site — Belzoni, Mississippi, United States
- Novartis Investigative Site — Jackson, Mississippi, United States
- Novartis Investigative Site — St Louis, Missouri, United States
- Novartis Investigative Site — Buffalo, New York, United States
- Novartis Investigative Site — Cincinnati, Ohio, United States
- Novartis Investigative Site — Houston, Texas, United States
- Novartis Investigative Site — Lake Jackson, Texas, United States
- Novartis Investigative Site — Pasadena, Texas, United States
- Novartis Investigative Site — Caba, Buenos Aires, Argentina
- Novartis Investigative Site — Ramos Mejía, Buenos Aires, Argentina
- Novartis Investigative Site — Rosario, Santa Fe Province, Argentina
- Novartis Investigative Site — Barranquilla, Atlántico, Colombia
- Novartis Investigative Site — Barranquilla, Colombia
- Novartis Investigative Site — Paris, France
- Novartis Investigative Site — Berlin, Germany
- Novartis Investigative Site — Nuremberg, Germany
- Novartis Investigative Site — Athens, Athens, Greece
- Novartis Investigative Site — Athens, Athens, Greece
- Novartis Investigative Site — Thessaloniki, Greece, Greece
- Novartis Investigative Site — Treviglio, BG, Italy
- Novartis Investigative Site — Pisa, PI, Italy
- Novartis Investigative Site — San Daniele del Friuli, UD, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.